About the Conference
The Trans-Pacific Health Sciences Dialogue is a meeting for C-level biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2014 Trans-Pacific Health Sciences Dialogue!
In 2015, the Trans-Pacific Health Sciences Dialogue will be held at:
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for senior biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.
Industry News from FiercePharmaAsia
- Pharma market bets on ASEAN in focus ahead of economic pact
At the end of 2015, the Association of Southeast Asian Nations (ASEAN) will launch an economic union that has already seen a slew of device and drug companies start or expand regional hubs in Singapore to sell into those markets.
Industry News from PharmAsia
- ViroMed Preps US Trial For First Diabetic Ulcer Gene TherapyAfter receiving US FDA approval to start a Phase III clinical trial with its gene therapy for diabetic peripheral neuropathy earlier this year, South Korea’s ViroMed is set for another Phase III study in the US, this time for a chronic non-healing ischemic diabetic foot ulcer therapy, which is the first gene therapy to be developed for this indication and which the firm is looking to partner.<img src="http://feeds.feedburner.com/~r/_PharmAsiaNews/~4/wld207kdBbY" height="1" width="1" alt="" />